To provide a more robust exploration of the contribution of PRMT5 in CLL disease progression, L25 Eμ-PRMT5 mice were crossed to Eμ-TCL1 mice to generate double transgenic animals (Eμ-PRMT5/TCL1). This evidence concerns the gene TCL1A and B-cell chronic lymphocytic leukemia.